TEQ of Prothioconazole TC 98% in  EU

Our Prothioconazole Technical Material Secures EUEquivalence Registration After Over Five Years of Efforts

After more than five years of hard workand persistent efforts, our company has successfully obtained the EUEquivalence Registration for Prothioconazole tech 98%. This landmarkachievement marks a significant milestone in our international market expansionstrategy, opening up broader prospects for our business development in theEuropean Union (EU) market.

Since launching the EU registrationproject for prothioconazole technical material, our R&D, quality controland regulatory teams have worked closely together. We have strictly followedthe EU’s stringent regulatory requirements for pesticide registration. Thesuccessful acquisition of the EU equivalence registration not only verifies theexcellent quality and compliance of our Prothioconazole technical material, butalso demonstrates our strong capabilities in meeting international advancedtechnical and regulatory standards.

Moreover, the successful acquisition ofthe EU equivalence registration for Prothioconazole 98% TC has laid a solidfoundation for our company to further develop EU-related businesses. In thefuture, we will take this as an opportunity to continue to increase investmentin R&D and innovation of pesticide products, optimize our productstructure, and actively explore more product registration opportunities in theEU market. At the same time, we will strengthen our market operation andservice capabilities in the EU region, improve the visibility and influence inthe international market, and strive to become a more competitive internationalsupplier of pesticide technical materials.

We would like to express our sinceregratitude to all teams that have contributed to this registration project, aswell as to the relevant EU regulatory authorities for their professionalguidance and review during the registration process. We are confident that withthis achievement, we will achieve greater success in the EU market and createmore value for our customers, shareholders and the society.

For inquiries of Prothioconazole, pleasecontact us by email.